Immunology and Microbiology
Wart Virus
100%
Human Papillomavirus Type 16
88%
Vaccine Efficacy
69%
Papillomaviridae
66%
Vaccination Policy
52%
Mouse
50%
Virus-Like Particle
50%
Capsid
47%
Epitope
32%
Cervarix
30%
Neutralizing Antibody
26%
Neutralization
23%
Virion
23%
Monospecific Antibody
23%
Immune Response
19%
Bovine Papillomavirus Type 1
14%
DNA Vaccine
14%
Titer
14%
Cytotoxic T-Cell
13%
Antibody Response
13%
Cell Surface
12%
Virus Like Particle Vaccine
12%
Proteasome
12%
Amino Terminal Sequence
10%
Antibody Blood Level
9%
Monoclonal Antibody
9%
Antigen Specificity
9%
L1 (Protein)
8%
Antiserum
8%
Human Papillomavirus Type 18
8%
Dendritic Cell
7%
T Cell
7%
Adjuvant
7%
Blood Plasma
6%
Squamous Cell
6%
Immunotherapy
6%
Immunogenicity
6%
Tumor Antigen
6%
HPV Vaccine
6%
Autoantibodies
6%
Mouse Model
6%
Wild Type
6%
Cottontail Rabbit Papillomavirus
5%
Phosphoryl Lipid A
5%
Antibody Titer
5%
Surface Property
5%
Agonist
5%
Human Papillomavirus Type 11
5%
Mus musculus
5%
Capsomere
5%
Keyphrases
High-risk Human Papillomavirus (HR-HPV)
70%
HPV16
39%
Virus-like
33%
Cervical Cancer
30%
Vaccination
28%
Human Papillomavirus Vaccine
18%
Ovarian Cancer
17%
Papillomavirus Infections
17%
Neutralizing Antibodies
13%
Capsid
12%
Cross-neutralization
12%
Human Papillomavirus Types
11%
DNA Vaccine
9%
Tumor
9%
Virion
9%
Pseudovirion
8%
Epitope
7%
Capsid Protein
7%
Rpn13
7%
Bovine Papillomavirus
7%
Neutralizing Epitope
7%
Minor Capsid Protein
6%
Multimers
5%
Vaccine Target
5%
Capsomeres
5%
ADRM1
5%
Immunization
5%
Type-specific
5%
Cell Surface
5%
Specific Antibodies
5%
HPV16 E7
5%
Medicine and Dentistry
Wart Virus
35%
Ovarian Cancer
25%
Malignant Neoplasm
24%
Cervical Cancer
24%
Human Papillomavirus Type 16
20%
Wart Virus Vaccine
14%
Neoplasm
13%
Infection
13%
Proteasome
12%
Cancer
8%
Ubiquitin
8%
Disease
8%
Krukenberg Tumor
7%
Virus Like Agent
7%
Papillomavirus Infection
7%
Precursor
6%
Papillomaviridae
6%
Immunotherapy
6%
Tumor Antigen
6%
Antibody Response
6%
Ovarian Tumor
6%
Capsid Protein
6%
DNA Vaccine
5%
Cancer Cell
5%
Carcinogenesis
5%
Serous Carcinoma
5%
CA-125
5%